338 related articles for article (PubMed ID: 16249345)
1. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
Conway JG; McDonald B; Parham J; Keith B; Rusnak DW; Shaw E; Jansen M; Lin P; Payne A; Crosby RM; Johnson JH; Frick L; Lin MH; Depee S; Tadepalli S; Votta B; James I; Fuller K; Chambers TJ; Kull FC; Chamberlain SD; Hutchins JT
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16078-83. PubMed ID: 16249345
[TBL] [Abstract][Full Text] [Related]
2. Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.
Conway JG; Pink H; Bergquist ML; Han B; Depee S; Tadepalli S; Lin P; Crumrine RC; Binz J; Clark RL; Selph JL; Stimpson SA; Hutchins JT; Chamberlain SD; Brodie TA
J Pharmacol Exp Ther; 2008 Jul; 326(1):41-50. PubMed ID: 18434589
[TBL] [Abstract][Full Text] [Related]
3. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
[TBL] [Abstract][Full Text] [Related]
4. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
[TBL] [Abstract][Full Text] [Related]
5. Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV neuropathogenesis.
Gerngross L; Lehmicke G; Belkadi A; Fischer T
J Neuroinflammation; 2015 Mar; 12():58. PubMed ID: 25886134
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH
J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
[TBL] [Abstract][Full Text] [Related]
8. M-CSF Receptor Antagonists Inhibit the Initiation and Progression of Hepatocellular Carcinoma in Mice.
Akazawa Y; Kono H; Hara M; Furuya S; Nakata Y; Wakana H; Fukushima H; Sun C; Fujii H; Ichikawa D
Anticancer Res; 2019 Sep; 39(9):4787-4794. PubMed ID: 31519580
[TBL] [Abstract][Full Text] [Related]
9. Selective M2 Macrophage Depletion Leads to Prolonged Inflammation in Surgical Wounds.
Klinkert K; Whelan D; Clover AJP; Leblond AL; Kumar AHS; Caplice NM
Eur Surg Res; 2017; 58(3-4):109-120. PubMed ID: 28056458
[TBL] [Abstract][Full Text] [Related]
10. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species.
Soto-Diaz K; Vailati-Riboni M; Louie AY; McKim DB; Gaskins HR; Johnson RW; Steelman AJ
Front Immunol; 2021; 12():734349. PubMed ID: 34899694
[TBL] [Abstract][Full Text] [Related]
11. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
[TBL] [Abstract][Full Text] [Related]
12. Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression.
Ryder M; Gild M; Hohl TM; Pamer E; Knauf J; Ghossein R; Joyce JA; Fagin JA
PLoS One; 2013; 8(1):e54302. PubMed ID: 23372702
[TBL] [Abstract][Full Text] [Related]
13. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
Priceman SJ; Sung JL; Shaposhnik Z; Burton JB; Torres-Collado AX; Moughon DL; Johnson M; Lusis AJ; Cohen DA; Iruela-Arispe ML; Wu L
Blood; 2010 Feb; 115(7):1461-71. PubMed ID: 20008303
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-alpha production.
Nishiki S; Hato F; Kamata N; Sakamoto E; Hasegawa T; Kimura-Eto A; Hino M; Kitagawa S
Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1302-11. PubMed ID: 14736711
[TBL] [Abstract][Full Text] [Related]
15. JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia.
Manthey CL; Johnson DL; Illig CR; Tuman RW; Zhou Z; Baker JF; Chaikin MA; Donatelli RR; Franks CF; Zeng L; Crysler C; Chen Y; Yurkow EJ; Boczon L; Meegalla SK; Wilson KJ; Wall MJ; Chen J; Ballentine SK; Ott H; Baumann C; Lawrence D; Tomczuk BE; Molloy CJ
Mol Cancer Ther; 2009 Nov; 8(11):3151-61. PubMed ID: 19887542
[TBL] [Abstract][Full Text] [Related]
16. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.
Swierczak A; Cook AD; Lenzo JC; Restall CM; Doherty JP; Anderson RL; Hamilton JA
Cancer Immunol Res; 2014 Aug; 2(8):765-76. PubMed ID: 25005824
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood.
Eda H; Zhang J; Keith RH; Michener M; Beidler DR; Monahan JB
Cytokine; 2010 Dec; 52(3):215-20. PubMed ID: 20829061
[TBL] [Abstract][Full Text] [Related]
18. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages.
Hatch WC; Ganju RK; Hiregowdara D; Avraham S; Groopman JE
Blood; 1998 May; 91(10):3967-73. PubMed ID: 9573036
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cFMS signaling in HIV production by brain macrophages and microglia.
Gerngross L; Fischer T
J Neurovirol; 2015 Jun; 21(3):249-56. PubMed ID: 25060299
[TBL] [Abstract][Full Text] [Related]
20. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
